MVST - NASDAQ

Thank you for standing by. This is your conference operator. Welcome to the Microvast Third Quarter 2022 Earnings Call. [Operator Instructions]. I would now like to turn the conference over to Monica Gould, Investor Relations for Microvast. Please go ahead.

Thank you, , and thank you to the audience for joining us today. Sascha Kelterborn, President and Chief Revenue Officer; and Craig Webster, Chief Financial Officer, will host today's call. Ahead of this call, Microvast issued its third quarter 2022 earnings press release, which can be found on the Investor Relations section of our website at ir.microvast.com. In addition, we have posted a slide presentation to our website to accompany management's prepared remarks. As a reminder, please note that we will be making forward-looking statements on this call. These statements are based on current expectations and assumptions and reflect our views only as of today. It should not be relied upon as representative about views as of any subsequent date and we undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. These statements are subject to a variety of risks and uncertainties that could cause actual results to differ materially from expectations. For further discussion of the material risks and other important factors that could affect our financial results, please refer to our filings with the SEC, including our annual report on Form 10-K filed on March 29, 2022, and the 10-Q filed earlier today. In addition, during today's call, we may discuss non-GAAP financial measures, including adjusted gross profit, adjusted net loss and adjusted EBITDA, which we believe are useful as supplemental measures of Microvast's performance. These non-GAAP measures should be considered in addition to and not as a substitute for or in isolation from GAAP results. These non-GAAP measures have been reconciled to their most comparable GAAP metric in the tables included at the end of our press release. A webcast replay of this call will also be available on the Investor Relations section of our company website. And with that, I'll turn the call over to Sascha for some opening remarks.

Thank you, Monica. Thank you all for joining us. Everyone, please turn to Slide 4 as I cover a few highlights from the third quarter. We posted a 4.7% revenue growth during the quarter, delivering $38.6 million in Q3 2022, despite continuing difficult market conditions in Europe, customer supply chain challenges and currency headwinds. We ended the third quarter with a strong backlog of $140.6 million, driven by a healthy order intake of $81.9 million, led by a strong demand in China. Some key wins during the third quarter included an order from SAIC for over $24 million and an order from BA

Thank you, Sascha. I'll spend the next few minutes discussing our Q3 2022 financial results. Please turn to Slide 7, I'll summarize the main line items from our Q3 P&L. First off, we achieved third quarter revenue growth of 4.7% to $38.6 million from $36.9 million in Q3 2021. I will take you through the geographic breakdown in a later slide, but I would like to note that this marks the seventh quarter in a row that we have shown year-over-year revenue growth. This came despite some challenges we encountered during the quarter, as Sascha noted earlier, along with some currency headwinds. On a year-to-date basis, revenue was $139.7 million, up 64% and from $85.2 million in the prior 9-month period. We posted a gross profit of $2 million in Q3 2022 compared to gross loss of $35.9 million in the prior period. After adjusting for noncash settled share-based compensation expense in our cost of sales, adjusted gross profit was $4 million in Q3 2022, compared to adjusted gross loss of $33.6 million in Q3 2021. This translates into an adjusted gross margin of 10.2% in Q3 2022, compared to negative 91.1% in Q3 2021, a 101.3 percentage point improvement. Operating expenses were $39.6 million in Q3 2022 compared to $78 million in Q3 2021. The largest contributor to the decrease in operating expenses was the decline in SBC expense, which totaled $17.3 million in the quarter compared to in Q3 2021. The higher SBC in the prior year quarter was a result of recognizing $39.2 million of SBC expense upon accelerated vesting in connection with the business combination. As I mentioned previously, noncash SBC expense was a significant contributor to both GAAP operating expenses and operating losses. We believe a more accurate representation of our financial performance, especially as it relates to cash operating expenses and operating loss is as illustrated in Slide 8. After adjusting for noncash SBC expense in SG&A, our adjusted operating expense in Q3 2022 was $22.3 million. GAAP net loss was $36.5 million in Q3 2022 compared to net loss of $116.5 million in Q3 2021. After adjusting for noncash SBC expense and changes in fair value of our warrant liability and convertible notes, adjusted net loss was $17.4 million in Q3 2022 compared to $65.1 million in Q3 2021. Reconciliations of these non-GAAP metrics to the most comparable GAAP metrics are included in the tables at the end of our earnings press release. Slide 9 shows the geographic breakdown of our revenue for the 3- and 9-month periods ended September 30, 2022, compared to the prior year period. As you can see, for the third quarter, our China business showed a 35% increase year-over-year. This was partially offset by a decline in other Asia Pacific markets of 39% as potential customer orders linked the success of their did not materialize, and some confirmed orders were pushed out to Q4. As a result of the challenging market conditions in Europe we noted earlier, revenue in the region declined 30% compared to Q3 2021. However, we have some exciting projects coming up in the region, especially in anticipation of our new 53.5 ampere-hour cell and we expect the growth rate to pick up starting in 2023. Our balance sheet remains solid, as you will see on Slide 10. We ended the quarter with cash, cash equivalents and restricted cash of $415.7 million. Net cash provided by operating activities during the quarter was $4.9 million, which was primarily due to the cash collections from customers reducing our account receivables and notes receivables. Negative free cash flow of $11.9 million was mostly as a result of our CapEx spend on Huzhou 3.1 and Clarksville 1A in Q3 2022, which totaled $12.8 million. We also had capital expenditures totaling $4 million from improvements to our existing facilities and ongoing R&D projects. Our current estimates on our capital expenditure for the fourth quarter will be in the range of $90 million to $120 million and will primarily be used for our capacity expansion projects. As our payments are determined by construction and equipment delivery milestones, it may be the case that some of these payments are pushed out into 2023. In our last call, I explained that as we derisk the construction phase of our capacity expansions and have multiyear orders in place from our broad and growing customer base, especially those in Europe and the U.S., we would add leverage to our balance sheet. I'm pleased to report that during the quarter, we completed a $111 million project finance facility to support our Huzhou expansion with a syndicate of banks. This is a full year amortizing loan with a December 2026 maturity and the current interest rate is 4.8%. With the benefit of this debt financing, we expect to close the year with at least $250 million in cash, cash equivalents and restricted cash. The Huzhou capacity expansion brings our new high power and high energy cells online and supports our growth targets for 2023 and beyond. Manufacturing equipment deliveries and installation began in the third quarter, and our efforts are focused on ramping up production to meet very strong orders, especially for our new cells. We currently expect Clarksville to begin serial production in Q4 2023 and be well positioned to take advantage of the recently announced initiatives under the Inflation Reduction Act, or the IRA. Please turn to Slide 11, which details some of the most significant benefits of the IRA to Microvast. The most notable of which is a tax credit of $35 per kilowatt hour for battery cells and $10 per kilowatt hour for battery modules, both of which will be produced in our Clarksville facility. This translates to a potential tax credit of $45 million per gigawatt hour of cell and module production with the initial phase of Clarksville supporting 2 gigawatt hours. Given the level of customer interest in this facility across our energy storage and commercial vehicle solutions, we are already planning to increase this to 4 gigawatt hours. Aside from the clear technological advantages of the 53.5 ampere-hour cell that is produced at Clarksville, there is the added benefit of this qualifying as domestic content under the IRA, which allows some of our customers to obtain an incremental 10% investment tax credit. With that, I will turn it back over to Sascha to review the outlook.

Thanks, Craig. Please turn to Slide 14. We are tightening annual revenue guidance for the full year, which is expected to be in the range of 35% to 40% for 2022. Our forecasted contracted revenue remains strong as our business with Western customers is poised for further growth. We continue to be optimistic about opportunities to grow market share and penetrate new markets, both geographically and with future innovative products. We look forward to the full deployment of our recently launched products, which are expected to drive sales growth in 2023 and beyond as they are incorporated into much anticipated upcoming vehicle launches. Accordingly, we have a good visibility on 2023 as a result of 2 large SOP projects for deliveries to commercial vehicle customers in Europe, which we currently estimate at in revenue with potential upside and as well across our new energy storage business, which will add further positive momentum to our 2023 outlook. We are, therefore, planning for sustainable global increase in customer volume next year, which truly sets the platform for future years of growth. Execution continues to be critical, and to achieve our target, we are focusing our efforts on, first, revenue growth through new multiyear supply contracts with existing and new customers; second, completing capacity expansion projects to service increasing customer demands; and third, driving margin improvement as we scale the business. We are very excited to begin planning our [indiscernible] polyaramid separator facility in collaboration with General Motors, for which we recently received a $200 million grant from the Department of Energy. This not only validates our leading-edge technology but also sustainably expands our addressable market. As our team works hard to execute significant progress has made over the last few months with multiple new U.S. government funding programs, we expect the inflation Reduction Act of 2022 to be important [indiscernible], advancing clean energy initiatives and helping to reduce carbon emissions in the U.S. while creating even more exciting direct and indirect business opportunities for Microvast going forward. Our global Microvast team, our focus-oriented culture and our ability to execute has been and will be a competitive advantage of Microvast. And I would like to thank personally the Microvast team for their tireless work and commitment to our mission before turning the call back over to the operator to start the Q&A session.

[Operator Instructions]. Our first question is from Colin Rusch with Oppenheimer & Company.

Can you give us a little bit of a sense of the cadence on gross margin improvement? Really happy to see the progress that you made during the quarter, even at lower revenue levels. But curious how you see that playing out through the balance of 4Q and into the early part of 2023.

Thanks for that, Colin. I'd say, look, we're starting to see a lot of [indiscernible] is we're increasing prices. We're increasing prices. Customers were expecting this. Those negotiations have gone well. It really underpins like our forecast for next year. And tied into that as well is that as we have a lot of visibility around this 53.5 ampere-hour cell, it incredibly helps with production planning, so we get the scale effect, volume effect and we really see that playing out into 2023.

Excellent. And then in terms of customer engagement around medium and heavy duty, obviously, some of these ramps have been mixed in terms of timing, given any number of issues around supply chain. But I'm curious what you're seeing so far in terms of the move into production on these programs and the ability of these customers to take product in anticipation of their production ramps.

Colin, you probably have heard on the IAA this year in Hannover, on the biggest global commercial vehicle trade show. The CEO of Iveco announced the start of production of Iveco eDAILY. And as everybody knows, we are the battery supplier. So the SOP starts already in December, and we have further upcoming SOP projects, as I mentioned already, in that field beginning of next year. So electrification is starting. There was a delay through the pandemic, and now it's moving ahead. That's the reason why we really have a positive outlook into the future.

And so you're seeing activity right now. Are they going through kind of a measured slow start here so far? Or are you seeing them really go full force out of the gate?

You have -- in every SOP, you have a classical ramp-up phase. So they are ramping up. So '23 will be the ramp-up phase, moving ahead, moving forward, backed up by a lot of governmental projects. They need to -- every commercial vehicle manufacturer has to improve his CO2 footprint. So everything plays into our cards, and we are very confident in that case over the next years that there will be a quick ramp up in that area.

That's super helpful. And then a final one for me is just with this DOE grant, which has obviously went through a fairly competitive process, can you talk a little bit about the customer engagement since that announcement? Obviously, I think it's an important validation of what you guys are up to. But curious as to how that response has been so far.

Colin, it's been super positive. My colleagues, Dr. Mattis and Shane did an awesome job with DOE. That grant, it's a grant. We don't have to pay it back. It's a huge validation of Microvast, the technologies that we have. They want to have these technologies exclusively in the U.S. And then GM's collaboration with us, again, they've been very close to the development of this technology. And we're looking forward to in exploring ways how we have to move this business forward. What we're hearing from them so far is that they like this as very much a stand-alone entity that they want to be very close to this technology. Other investors are also interested. And then if we do it like that, it really [indiscernible] that becomes a -- we run it separately and it will be spun off at some point.

[Operator Instructions].

And while we wait for additional questions to come in, I'll just read one that we received through the IR e-mail. And this is about our recently announced energy storage division, if you could talk a little bit about how that is being received and what kind of feedback you're getting from customers.

Sure.

Great. And then going back to the large DOE grant that we received, can you talk a little bit about the selection process and how Microvast was able to secure such a large grant?

Sure. It's really down to the technology. It's a polyaramid separator. It took Microvast 10 years to perfect that technology. The separator is the most critical component in the battery for safety. Microvast is a safety-first company. It's the most critical part of the battery. We have large and extensive patent protection on that. And I think it was just a true recognition of, one, that we can develop technologies but, importantly, we can also commercialize them. And that's why we received such a significant grant.

So that looks like that's it for the questions that we've received. Sascha, do you have any other closing remarks before we close up the call?

Yes. I would like to thank the audience for participating today. And I wish everybody a great evening. And we will report soon again with further positive news. Thanks a lot for being with us today.